Can SpineGuard Shake Up the $7 Billion Market for Spinal Fusion?

Company’s PediGuard® device reduces by 30% spine surgeons’ radiation exposure from fluoroscopy while maintaining a 97.5% accurate pedicle screw placement during lumbar spine fusion

SAN FRANCISCO & PARIS--(BUSINESS WIRE)--Click here to view feature story in The Sentinel

SpineGuard and its breakthrough PediGuard® platform are featured in The Sentinel, a publication of OneMedPlace.

Co-founded in 2009 by Pierre Jérôme and Stéphane Bette, former executives at Medtronic Sofamor-Danek and SpineVision, SpineGuard’s primary objective is to establish its FDA-cleared and CE Marked PediGuard® device as the global standard of care for safer pedicle screw placement in spine surgery.

About the PediGuard® platform

Co-invented by Maurice Bourlion, Ph.D., Ciaran Bolger, M.D., Ph.D., and Alain Vanquaethem, Biomedical Engineer, PediGuard is the world’s first and only handheld device capable of alerting surgeons to potential pedicular or vertebral breaches. Real-time feedback is provided via audio and visual signals. More than 20,000 procedures have been performed with PediGuard on all continents. Several studies published in peer-reviewed medical and scientific journals have demonstrated that PediGuard presents an average accuracy of 97%, doubles the pedicle breach-detection rate, limits radiation exposure by up to 73%, decreases by 15% the average time for pedicle screw placement and provides a 3-fold reduction in neuro-monitoring events.

SpineGuard’s mission is to make spine surgery safer. The company has offices in San Francisco and Paris. For further information, visit www.spineguard.com.